CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 536 of 652
Non-Antibody Products
Page 536 of 652
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| R-1 Methanandamide | A potent CB1 receptor agonist in the methanandamide series; selective for… | 10 mg | 90070-10 | More Info |
| R-1 Methanandamide | A potent CB1 receptor agonist in the methanandamide series; selective for… | 25 mg | 90070-25 | More Info |
| R-1 Methanandamide | A potent CB1 receptor agonist in the methanandamide series; selective for… | 5 mg | 90070-5 | More Info |
| R-1 Methanandamide | A potent CB1 receptor agonist in the methanandamide series; selective for… | 50 mg | 90070-50 | More Info |
| R-2 Methanandamide | A CB analog with a methyl group in the (R) configuration at C-2 of the eth… | 10 mg | 90074-10 | More Info |
| R-2 Methanandamide | A CB analog with a methyl group in the (R) configuration at C-2 of the eth… | 25 mg | 90074-25 | More Info |
| R-2 Methanandamide | A CB analog with a methyl group in the (R) configuration at C-2 of the eth… | 5 mg | 90074-5 | More Info |
| R-1 Methanandamide Phosphate | A water soluble prodrug analog of AEA; similar activity to AEA in the grow… | 1 mg | 10004281-1 | More Info |
| R-1 Methanandamide Phosphate | A water soluble prodrug analog of AEA; similar activity to AEA in the grow… | 10 mg | 10004281-10 | More Info |
| R-1 Methanandamide Phosphate | A water soluble prodrug analog of AEA; similar activity to AEA in the grow… | 5 mg | 10004281-5 | More Info |
| 15(R)-15-methyl Prostaglandin A2 | A potential impurity in the production of commercial lots of bulk arbapros… | 1 mg | 10270-1 | More Info |
| 15(R)-15-methyl Prostaglandin A2 | A potential impurity in the production of commercial lots of bulk arbapros… | 10 mg | 10270-10 | More Info |
| 15(R)-15-methyl Prostaglandin A2 | A potential impurity in the production of commercial lots of bulk arbapros… | 5 mg | 10270-5 | More Info |
| 15(R)-15-methyl Prostaglandin D2 | The physiological actions of PGD2 include regulation of sleep, lowering of… | 1 mg | 12720-1 | More Info |
| 15(R)-15-methyl Prostaglandin D2 | The physiological actions of PGD2 include regulation of sleep, lowering of… | 500 µg | 12720-500 | More Info |
| 15(R)-15-methyl Prostaglandin E2 | A prodrug for the potent PGE2 analog 15(S)-15-methyl PGE2 designed for act… | 1 mg | 14725-1 | More Info |
| 15(R)-15-methyl Prostaglandin E2 | A prodrug for the potent PGE2 analog 15(S)-15-methyl PGE2 designed for act… | 500 µg | 14725-500 | More Info |
| 15(R)-15-methyl Prostaglandin F2α | A prodrug analog of 15(S)-15-methyl PGF2α designed for activation by… | 1 mg | 16730-1 | More Info |
| 15(R)-15-methyl Prostaglandin F2α | A prodrug analog of 15(S)-15-methyl PGF2α designed for activation by… | 500 µg | 16730-500 | More Info |
| 15(R)-15-methyl Prostaglandin F2α methyl ester | 15(R)-15-methyl PGF2α methyl ester is a lipid soluble prodrug form o… | 1 mg | 16734-1 | More Info |
| 15(R)-15-methyl Prostaglandin F2α methyl ester | 15(R)-15-methyl PGF2α methyl ester is a lipid soluble prodrug form o… | 500 µg | 16734-500 | More Info |
| (R)-MG132 | A potent, reversible, and cell permeable proteasome inhibitor; a more effe… | 1 mg | 13697-1 | More Info |
| (R)-MG132 | A potent, reversible, and cell permeable proteasome inhibitor; a more effe… | 10 mg | 13697-10 | More Info |
| (R)-MG132 | A potent, reversible, and cell permeable proteasome inhibitor; a more effe… | 25 mg | 13697-25 | More Info |
| (R)-MG132 | A potent, reversible, and cell permeable proteasome inhibitor; a more effe… | 5 mg | 13697-5 | More Info |
| R-(−)-α-Methylhistamine (hydrochloride) | A histamine H3 receptor agonist; inhibits the release of histamine induced… | 1 mg | 25601-1 | More Info |
| R-(−)-α-Methylhistamine (hydrochloride) | A histamine H3 receptor agonist; inhibits the release of histamine induced… | 10 mg | 25601-10 | More Info |
| R-(−)-α-Methylhistamine (hydrochloride) | A histamine H3 receptor agonist; inhibits the release of histamine induced… | 25 mg | 25601-25 | More Info |
| R-(−)-α-Methylhistamine (hydrochloride) | A histamine H3 receptor agonist; inhibits the release of histamine induced… | 5 mg | 25601-5 | More Info |
| R-(−)-Deprenyl (hydrochloride) | A selective, reversible inhibitor of MAO-B (Ki = 0.091 µM) over MAO-… | 1 g | 15046-1 | More Info |
| R-(−)-Deprenyl (hydrochloride) | A selective, reversible inhibitor of MAO-B (Ki = 0.091 µM) over MAO-… | 100 mg | 15046-100 | More Info |
| R-(−)-Deprenyl (hydrochloride) | A selective, reversible inhibitor of MAO-B (Ki = 0.091 µM) over MAO-… | 250 mg | 15046-250 | More Info |
| R-(−)-Deprenyl (hydrochloride) | A selective, reversible inhibitor of MAO-B (Ki = 0.091 µM) over MAO-… | 500 mg | 15046-500 | More Info |
| (R)-(−)-3,4-MDMA (hydrochloride) | An analytical reference standard categorized as an amphetamine; the inacti… | 1 mg | 33956-1 | More Info |
| (R)-(−)-Metalaxyl-d6 | An internal standard for the quantification of (R)-(−)-metalaxyl by… | 1 mg | 39575-1 | More Info |
| (R)-(−)-Metalaxyl-d6 | An internal standard for the quantification of (R)-(−)-metalaxyl by… | 10 mg | 39575-10 | More Info |
| (R)-(−)-Metalaxyl-d6 | An internal standard for the quantification of (R)-(−)-metalaxyl by… | 5 mg | 39575-5 | More Info |
| (R)-Modafinil | An analytical reference standard categorized as a nootropic and stimulant;… | 1 mg | 29910-1 | More Info |
| (R)-Modafinil | An analytical reference standard categorized as a nootropic and stimulant;… | 10 mg | 29910-10 | More Info |
| (R)-Modafinil | An analytical reference standard categorized as a nootropic and stimulant;… | 5 mg | 29910-5 | More Info |
| RN-1734 | A TRPV4 antagonist (IC50s = 2.3, 5.9, and 3.2 µM for human, mouse, a… | 10 mg | 24205-10 | More Info |
| RN-1734 | A TRPV4 antagonist (IC50s = 2.3, 5.9, and 3.2 µM for human, mouse, a… | 25 mg | 24205-25 | More Info |
| RN-1734 | A TRPV4 antagonist (IC50s = 2.3, 5.9, and 3.2 µM for human, mouse, a… | 5 mg | 24205-5 | More Info |
| RN-1747 | A TRPV4 agonist; selectively induces calcium influx in HEK293 cells expres… | 10 mg | 37573-10 | More Info |
| RN-1747 | A TRPV4 agonist; selectively induces calcium influx in HEK293 cells expres… | 25 mg | 37573-25 | More Info |
| RN-1747 | A TRPV4 agonist; selectively induces calcium influx in HEK293 cells expres… | 5 mg | 37573-5 | More Info |
| RN-1747 | A TRPV4 agonist; selectively induces calcium influx in HEK293 cells expres… | 50 mg | 37573-50 | More Info |
| RN-18 | An HIV-1 Vif inhibitor; inhibits Vif-mediated degradation of the DNA editi… | 1 mg | 23331-1 | More Info |
| RN-18 | An HIV-1 Vif inhibitor; inhibits Vif-mediated degradation of the DNA editi… | 10 mg | 23331-10 | More Info |
| RN-18 | An HIV-1 Vif inhibitor; inhibits Vif-mediated degradation of the DNA editi… | 25 mg | 23331-25 | More Info |
| RN-18 | An HIV-1 Vif inhibitor; inhibits Vif-mediated degradation of the DNA editi… | 5 mg | 23331-5 | More Info |
| RN-486 | A selective BTK inhibitor (Kds = 0.31 nM; IC50 = 4 nM); produces anti-infl… | 1 mg | 20536-1 | More Info |
| RN-486 | A selective BTK inhibitor (Kds = 0.31 nM; IC50 = 4 nM); produces anti-infl… | 10 mg | 20536-10 | More Info |
| RN-486 | A selective BTK inhibitor (Kds = 0.31 nM; IC50 = 4 nM); produces anti-infl… | 5 mg | 20536-5 | More Info |
| RN-1 (hydrochloride) | A potent, irreversible inhibitor of LSD1 (IC50 = 70 nM); penetrates the bl… | 1 mg | 18124-1 | More Info |
| RN-1 (hydrochloride) | A potent, irreversible inhibitor of LSD1 (IC50 = 70 nM); penetrates the bl… | 10 mg | 18124-10 | More Info |
| RN-1 (hydrochloride) | A potent, irreversible inhibitor of LSD1 (IC50 = 70 nM); penetrates the bl… | 5 mg | 18124-5 | More Info |
| RN-9893 (hydrochloride) | A TRPV4 antagonist (IC50s = 0.42 and 0.66 µM, respectively, for huma… | 1 mg | 29172-1 | More Info |
| RN-9893 (hydrochloride) | A TRPV4 antagonist (IC50s = 0.42 and 0.66 µM, respectively, for huma… | 5 mg | 29172-5 | More Info |
| (R)-nitro-Blebbistatin | A more stable form of (+)-blebbistatin, the inactive form of blebbistatin;… | 1 mg | 9001935-1 | More Info |
| (R)-nitro-Blebbistatin | A more stable form of (+)-blebbistatin, the inactive form of blebbistatin;… | 10 mg | 9001935-10 | More Info |
| (R)-nitro-Blebbistatin | A more stable form of (+)-blebbistatin, the inactive form of blebbistatin;… | 5 mg | 9001935-5 | More Info |
| 9(R)-11-nor-9-carboxy-Δ6a,10a-THC | An analytical reference standard that is structurally similar to known phy… | 1 mg | 38237-1 | More Info |
| 9(R)-11-nor-9-carboxy-Δ6a,10a-THC | An analytical reference standard that is structurally similar to known phy… | 500 µg | 38237-500 | More Info |
| (R)-Norketamine (hydrochloride) | An analytical reference standard categorized as an arylcyclohexylamine; an… | 1 mg | 37821-1 | More Info |
| (R)-Norketamine (hydrochloride) | An analytical reference standard categorized as an arylcyclohexylamine; an… | 5 mg | 37821-5 | More Info |
| Ro 01-6128 | A positive allosteric modulator of mGluR1; potentiates glutamate-induced c… | 1 mg | 11991-1 | More Info |
| Ro 01-6128 | A positive allosteric modulator of mGluR1; potentiates glutamate-induced c… | 10 mg | 11991-10 | More Info |
| Ro 01-6128 | A positive allosteric modulator of mGluR1; potentiates glutamate-induced c… | 5 mg | 11991-5 | More Info |
| Ro 0335 | An NNRTI and active metabolite of elsulfavirine; inhibits HIV-1 reverse tr… | 10 mg | 36124-10 | More Info |
| Ro 0335 | An NNRTI and active metabolite of elsulfavirine; inhibits HIV-1 reverse tr… | 100 mg | 36124-100 | More Info |
| Ro 0335 | An NNRTI and active metabolite of elsulfavirine; inhibits HIV-1 reverse tr… | 5 mg | 36124-5 | More Info |
| Ro 0335 | An NNRTI and active metabolite of elsulfavirine; inhibits HIV-1 reverse tr… | 50 mg | 36124-50 | More Info |
| Ro 08-2750 | A p75NTR ligand; completely inhibits NGF binding to p75NTR in PC12 cells a… | 1 mg | 28772-1 | More Info |
| Ro 08-2750 | A p75NTR ligand; completely inhibits NGF binding to p75NTR in PC12 cells a… | 10 mg | 28772-10 | More Info |
| Ro 08-2750 | A p75NTR ligand; completely inhibits NGF binding to p75NTR in PC12 cells a… | 5 mg | 28772-5 | More Info |
| Ro 106-9920 | A small molecule inhibitor of NF-κB-dependent expression of TNF-&alp… | 1 mg | 15373-1 | More Info |
| Ro 106-9920 | A small molecule inhibitor of NF-κB-dependent expression of TNF-&alp… | 10 mg | 15373-10 | More Info |
| Ro 106-9920 | A small molecule inhibitor of NF-κB-dependent expression of TNF-&alp… | 5 mg | 15373-5 | More Info |
| Ro 20-1724 | A cell-permeable, selective PDE4 inhibitor (IC50 = 2 µM); inhibits t… | 100 mg | 18272-100 | More Info |
| Ro 20-1724 | A cell-permeable, selective PDE4 inhibitor (IC50 = 2 µM); inhibits t… | 25 mg | 18272-25 | More Info |
| Ro 20-1724 | A cell-permeable, selective PDE4 inhibitor (IC50 = 2 µM); inhibits t… | 50 mg | 18272-50 | More Info |
| Ro 3280 | A selective Plk1 inhibitor (IC50s = 3 and 6 nM in an enzymatic assay and H… | 1 mg | 21669-1 | More Info |
| Ro 3280 | A selective Plk1 inhibitor (IC50s = 3 and 6 nM in an enzymatic assay and H… | 10 mg | 21669-10 | More Info |
| Ro 3280 | A selective Plk1 inhibitor (IC50s = 3 and 6 nM in an enzymatic assay and H… | 25 mg | 21669-25 | More Info |
| Ro 3280 | A selective Plk1 inhibitor (IC50s = 3 and 6 nM in an enzymatic assay and H… | 5 mg | 21669-5 | More Info |
| Ro 3306 | A cell-permeable, reversible inhibitor of Cdk1, showing preference for Cdk… | 1 mg | 15149-1 | More Info |
| Ro 3306 | A cell-permeable, reversible inhibitor of Cdk1, showing preference for Cdk… | 10 mg | 15149-10 | More Info |
| Ro 3306 | A cell-permeable, reversible inhibitor of Cdk1, showing preference for Cdk… | 5 mg | 15149-5 | More Info |
| Ro 3306 | A cell-permeable, reversible inhibitor of Cdk1, showing preference for Cdk… | 50 mg | 15149-50 | More Info |
| Ro 41-0960 | A COMT inhibitor; prevents L-DOPA-induced dopaminergic neuron loss in prim… | 10 mg | 29621-10 | More Info |
| Ro 41-0960 | A COMT inhibitor; prevents L-DOPA-induced dopaminergic neuron loss in prim… | 25 mg | 29621-25 | More Info |
| Ro 41-0960 | A COMT inhibitor; prevents L-DOPA-induced dopaminergic neuron loss in prim… | 5 mg | 29621-5 | More Info |
| Ro 48-8071 | An oxidosqualene cyclase inhibitor with cholesterol lowering activity; inh… | 10 mg | 10006415-10 | More Info |
| Ro 48-8071 | An oxidosqualene cyclase inhibitor with cholesterol lowering activity; inh… | 100 mg | 10006415-100 | More Info |
| Ro 48-8071 | An oxidosqualene cyclase inhibitor with cholesterol lowering activity; inh… | 5 mg | 10006415-5 | More Info |
| Ro 48-8071 | An oxidosqualene cyclase inhibitor with cholesterol lowering activity; inh… | 50 mg | 10006415-50 | More Info |
| Ro 4929097 | A potent, selective inhibitor of γ-secretase (IC50 = 4 nM) that bloc… | 1 mg | 19996-1 | More Info |
| Ro 4929097 | A potent, selective inhibitor of γ-secretase (IC50 = 4 nM) that bloc… | 10 mg | 19996-10 | More Info |
| Ro 4929097 | A potent, selective inhibitor of γ-secretase (IC50 = 4 nM) that bloc… | 5 mg | 19996-5 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile